Cargando…

Cochlear Implant in Patients with Intralabyrinthine Schwannoma without Tumor Removal

(1) Background: Schwannomas of the vestibulocochlear nerve are benign, slow-growing tumors, arising from the Schwann cells. When they originate from neural elements within the vestibule or cochlea, they are defined as intralabyrinthine schwannomas (ILSs). Cochlear implant (CI) has been reported as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Laborai, Andrea, Ghiselli, Sara, Cuda, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788267/
https://www.ncbi.nlm.nih.gov/pubmed/35076488
http://dx.doi.org/10.3390/audiolres12010004
_version_ 1784639523043409920
author Laborai, Andrea
Ghiselli, Sara
Cuda, Domenico
author_facet Laborai, Andrea
Ghiselli, Sara
Cuda, Domenico
author_sort Laborai, Andrea
collection PubMed
description (1) Background: Schwannomas of the vestibulocochlear nerve are benign, slow-growing tumors, arising from the Schwann cells. When they originate from neural elements within the vestibule or cochlea, they are defined as intralabyrinthine schwannomas (ILSs). Cochlear implant (CI) has been reported as a feasible solution for hearing restoration in these patients. (2) Methods: Two patients with single-sided deafness (SSD) due to sudden sensorineural hearing loss and ipsilateral tinnitus were the cases. MRI detected an ILS. CI was positioned using a standard round window approach without tumor removal. (3) Results: The hearing threshold was 35 dB in one case and 30 dB in the other 6 mo after activation. Speech audiometry with bisillables in quiet was 21% and 27% at 65 dB, and the tinnitus was completely resolved or reduced. In the localization test, a 25.9° error azimuth was obtained with CI on, compared to 43.2° without CI. The data log reported a daily use of 11 h and 14 h. In order to not decrease the CI’s performance, we decided not to perform tumor exeresis, but only CI surgery to restore functional binaural hearing. (4) Conclusions: These are the sixth and seventh cases in the literature of CI in patients with ILS without any tumor treatment and the first with SSD. Cochlear implant without tumor removal can be a feasible option for restoring binaural hearing without worsening the CI’s performance.
format Online
Article
Text
id pubmed-8788267
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87882672022-01-26 Cochlear Implant in Patients with Intralabyrinthine Schwannoma without Tumor Removal Laborai, Andrea Ghiselli, Sara Cuda, Domenico Audiol Res Article (1) Background: Schwannomas of the vestibulocochlear nerve are benign, slow-growing tumors, arising from the Schwann cells. When they originate from neural elements within the vestibule or cochlea, they are defined as intralabyrinthine schwannomas (ILSs). Cochlear implant (CI) has been reported as a feasible solution for hearing restoration in these patients. (2) Methods: Two patients with single-sided deafness (SSD) due to sudden sensorineural hearing loss and ipsilateral tinnitus were the cases. MRI detected an ILS. CI was positioned using a standard round window approach without tumor removal. (3) Results: The hearing threshold was 35 dB in one case and 30 dB in the other 6 mo after activation. Speech audiometry with bisillables in quiet was 21% and 27% at 65 dB, and the tinnitus was completely resolved or reduced. In the localization test, a 25.9° error azimuth was obtained with CI on, compared to 43.2° without CI. The data log reported a daily use of 11 h and 14 h. In order to not decrease the CI’s performance, we decided not to perform tumor exeresis, but only CI surgery to restore functional binaural hearing. (4) Conclusions: These are the sixth and seventh cases in the literature of CI in patients with ILS without any tumor treatment and the first with SSD. Cochlear implant without tumor removal can be a feasible option for restoring binaural hearing without worsening the CI’s performance. MDPI 2022-01-10 /pmc/articles/PMC8788267/ /pubmed/35076488 http://dx.doi.org/10.3390/audiolres12010004 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Laborai, Andrea
Ghiselli, Sara
Cuda, Domenico
Cochlear Implant in Patients with Intralabyrinthine Schwannoma without Tumor Removal
title Cochlear Implant in Patients with Intralabyrinthine Schwannoma without Tumor Removal
title_full Cochlear Implant in Patients with Intralabyrinthine Schwannoma without Tumor Removal
title_fullStr Cochlear Implant in Patients with Intralabyrinthine Schwannoma without Tumor Removal
title_full_unstemmed Cochlear Implant in Patients with Intralabyrinthine Schwannoma without Tumor Removal
title_short Cochlear Implant in Patients with Intralabyrinthine Schwannoma without Tumor Removal
title_sort cochlear implant in patients with intralabyrinthine schwannoma without tumor removal
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788267/
https://www.ncbi.nlm.nih.gov/pubmed/35076488
http://dx.doi.org/10.3390/audiolres12010004
work_keys_str_mv AT laboraiandrea cochlearimplantinpatientswithintralabyrinthineschwannomawithouttumorremoval
AT ghisellisara cochlearimplantinpatientswithintralabyrinthineschwannomawithouttumorremoval
AT cudadomenico cochlearimplantinpatientswithintralabyrinthineschwannomawithouttumorremoval